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Abbreviations 
Anti-neutrophil cytoplasmic antibody (ANCA) 
Computerised tomography (CT) 
Ear, nose and throat (ENT) 
Cytoplasmic anti-neutrophil cytoplasmic antibody (C-ANCA) 
Perinuclear anti-neutrophil cytoplasmic antibody (P-ANCA) 
Myeloperoxidase (MPO) 
Proteinase 3 (PR3) 
Granulomatosis with polyangiitis (GPA) 
Cocaine-induced midline lesions (CIMDL) 
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Human Neutrophil Elastase (HNE) 
Abstract  
Objectives 
We analysed the spectrum of clinical manifestations of cocaine associated 
pseudovasculitis.  
Methods 
Clinical, serological, radiological and histological features of 14 patients with cocaine 
pseudovasculitis syndromes were included. 
Results 
Twelve patients had significant sinus thickening or erosive disease. Other multi-
system manifestations included vasculitic rashes, pulmonary lesions and peripheral 
neuropathy. All patients had positive ANCA titres at presentation. All patients were 
managed with corticosteroids +/- methotrexate and co-trimoxazole, 2 patients 
received cyclophosphamide.  
Conclusions 
Advanced erosive nasal septal defects and atypical ANCA patterns are suggestive of 
cocaine induced pseudovasculitis. Complete drug cessation may negate the need for 
exposure to potent immunosuppressive agents.  
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Introduction  
Cocaine is a potent illicit stimulant and ‘class A’ drug. It is the second most 
commonly used illicit drug amongst 16-59 year olds in England and Wales [1]. Acute 
intoxication with cocaine can cause euphoria and increased sociability. Cocaine is 
associated with multiple deleterious effects including acute psychosis, seizures, 
cerebrovascular accidents, cardiac arrhythmias, myocardial infarction and cardiac 
arrest. Cocaine has been implicated as a trigger for the development of multi-organ 
anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis [2-6]. It is 
increasingly recognised that cocaine may trigger a ‘pseudovasculitis’ presentation 
mimicking true idiopathic ANCA associated vasculitis (AAV) [6]. 
We describe the clinical and serological manifestations of 14 patients from a 
single centre presenting with syndromes closely mimicking AAV in subjects with a 
history of chronic cocaine use. 
Materials and Methods  
We retrospectively analysed 14 patients presenting consecutively between 
2000 and 2017 to the Rheumatology department at Guy’s and St. Thomas’ 
Hospitals, London. All patients disclosed chronic habitual cocaine use, although not 
necessarily at initial presentation.  All patients had blood samples analysed for 
ANCA antibodies, inflammatory markers, full blood count, liver and renal profiles. 
Eleven patients had computerised tomography (CT) imaging of the sinuses, 8 had 
chest CT scans. Ten patients had tissue biopsies (renal, skin or nasal/sinus) during 
clinical work-up.  
Analysis of the patient’s electronic medical records and clinic correspondence 
was undertaken as part of a service evaluation of routine practice. Application of the 
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NHS HRA research decision aid toolkit confirmed Research Ethics Committee 
approval was not required.  
Results  
There were 10 male and 4 female patients, median age 39 years (range 25-
52 years). All patients disclosed cocaine exposure, albeit not necessarily at initial 
presentation. Nine patients admitted regular cocaine use for up to 12 years prior to 
their first presentation to our service, 4 patients were actively abusing cocaine at first 
presentation confirmed by positive urine toxicology tests (patients 10, 11, 13 and 14). 
The mean duration of cocaine use was 9.6 years (range 6-15 years).  
Twelve patients had ear, nose and throat (ENT) involvement with sinus 
erosion or significant mucosal thickening on clinical and/or radiological assessment. 
Other clinical manifestations included vasculitic purpuric rash, inflammatory arthritis 
and peripheral neuropathy. Ten patients had tissue biopsies (renal, skin or sinus) 
during diagnostic assessment. Acute and chronic inflammatory changes were noted 
in all biopsy samples but no granulomas were visualised in the 10 patients who 
underwent sinus or nasal biopsy. One patient (patient 11) had 80% IgG4 plasma 
cells on nasal biopsy and raised serum IgG4 levels suggestive IgG4 disease. One 
patient (patient 9) had a skin biopsy with features of leucocytoclastic vasculitis. The 
same patient had evidence of glomerular red cell casts on urine cytology; 
subsequent renal biopsy suggested features of Henoch-Schonlein purpura/IgA 
vasculitis. No patients in our series had necrotizing glomerulonephritis, thrombotic 
microangiopathy or any evidence of cocaine associated cardiovascular disease.  
 The ANCA patterns were variable, both cytoplasmic and perinuclear ANCA 
patterns (C-ANCA and P-ANCA) were detected. All patients (14/14) were ANCA 
positive by immunofluorescence. Three patients had concordant ANCA patterns with 
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proteinase 3 (PR3) / myeloperoxidase (MPO) sub-serologies. Four patients (patients 
10, 11, 13, 14) had discordant ANCA patterns (P-ANCA, PR3 positive) with 
persistently positive ANCA on repeat assessment (all continued to abuse cocaine, 
confirmed on urine toxicology). Seven patients were ANCA positive but had 
PR3/MPO negative at first presentation. ANCA titres persisted in 8 patients despite 
clinical remission and patient reported drug cessation. ANCA titres were negative on 
repeat testing in 6 patients at serial follow-up visits after drug withdrawal and 
appropriate treatment.  
The baseline demographics, laboratory assessments, serological status and 
clinical manifestations (including histological findings where available) are presented 
in Table 1.   
All patients were managed with corticosteroids (median starting prednisolone 
dose 20mg daily); 10 received combination therapy with prednisolone, methotrexate 
and co-trimoxazole. Two patients (patients 2 and 6) each received a course of 
intravenous cyclophosphamide (6 x 500mg cyclophosphamide pulses fortnightly) 
during their clinical course. Patient 6 had cyclophosphamide adminsitered at another 
institution prior to his care being transferred to our unit. Patient 2 received 
cyclophosphamide because of advanced erosive nasal disease prior to disclosing 
chronic habitual cocaine usage. Nine patients (subjects 4, 6, 9, 10, 11, 12, 13, 14) 
remain under review in clinical remission, maintained on low dose prednisolone 
(median dose 7.5mg daily) +/- methotrexate in combination with co-trimoxazole with 
no further documented relapses. Six patients (subjects 1, 2, 3, 5, 7, 8) were lost to 
long-term follow-up after successful treatment for their acute illness due to recurrent 
non-attendance in clinic despite repeated invitation. They had however all achieved 
clinical remission prior to this.  
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Discussion 
Cocaine induced vasculitis may be difficult to distinguish from idiopathic AAV 
[7, 8]. Careful assessment of clinical, histological and serological patterns is required 
to make an accurate diagnosis particularly when considering treatment regimens [8].  
Cocaine induced disease is usually associated with localised rather than 
multi-system involvement and systemic upset [9, 10]. Necrosis and inflammation 
leading to midline sino-nasal destruction is associated with chronic cocaine use. This 
may be clinically indistinguishable from lesions resulting from AAV, but may be more 
destructive than lesions caused by granulomatosis with polyangiitis (GPA) [9]. This 
has been attributed to direct trauma with possible super-added infection with cocaine 
crystal insufflation, chemical adulterants or tissue ischaemia due to cocaine’s 
vasoconstricting properties [11]. Destruction of the nasal columella and upper lip is 
not a feature of AAV but is highly suggestive of cocaine induced disease [12]. Eight 
out of 14 patients in our series had evidence of localized ENT or upper respiratory 
tract pathology with nasal septal perforations. One patient had evidence of 
perforation of the hard palate which is considered pathognomic of cocaine-induced 
midline lesions (CIMDL) [9]. . Renal involvement is rare with cocaine induced 
disease but common in AAV [13, 14]. Comprehensive renal assessment is strongly 
advised if symptoms are suggestive of AAV. 
Histological patterns can help differentiate cocaine-induced lesions from AAV. 
Features including leucocytoclastic vasculitis and perivenulitis may be present in 
both conditions. In our series, 10 patients had tissue (renal, skin or sinus) biopsies, 
but no patients had granulomas evident. Extravascular inflammatory changes 
(including giant cells, micro-abscesses, foci of microscopic necrosis and 
granulomas) which are hallmarks of GPA are absent in cocaine induced disease [9]. 
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Although tissue biopsy is advised to support clinical diagnosis, caution must be 
exercised if there is sole reliance upon nasal or sinus biopsy to diagnose AAV as it 
may be non-diagnostic. Nasal and sinus biopsies can help in identifying atypical 
infections which can be destructive.  
Although ANCA positivity is reported in over 50% of patients with cocaine use, 
the pattern is usually atypical with very high titres compared to idiopathic AAV [10]. 
Patients with cocaine use may test positive for both MPO and PR3 [4, 5]. 
Determining whether cocaine exposure induces ANCA or whether patients develop 
unrelated idiopathic small/medium vessel vasculitis is challenging [7]. In drug 
associated ANCA positive vasculitides, the presence of ANCA may not have 
prognostic value [15]. The detection of Human Neutrophil Elastase (HNE) antibodies 
offers an additional diagnostic tool in differentiating cocaine induced disease from 
AAV. HNE antibodies have not been described in patients with GPA or microscopic 
polyangiitis [16]. Unfortunately, our centre did not have access to the HNE assay 
which is not widely available. Of note, patient 11 had features suggestive of IgG4 
related disease on nasal biopsy. The clinical manifestations of IgG4 disease and 
ANCA associated vasculitis may overlap and low titre ANCA in IgG4 disease may 
not be an unexpected finding [17].  
Levamisole (a synthetic imidazothiazole derivative previously used as an 
immunomodulatory and anti-helminthic agent in human and veterinary medicine) is a 
common adulterant of cocaine [18]. Levamisole may potentiate and enhance the 
psychoactive drug effects but has led a distinct clinical phenotype with neutropenia, 
agranulocytosis and retiform purpura that closely mimics AAV [19, 20]. Levamisole, 
can cause loss of tolerance to multiple neutrophil-specific proteins leading to high 
titre ANCA positivity; MPO and PR3 are frequently detected in addition to anti-
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nuclear antibodies, lupus anticoagulant and hypocomplementaemia. Autoantibodies 
are also formed to HNE, cathepsin G, and lactoferrin [10, 21]. Detecting levamisole 
is a challenging due to its short half-life and small percentage excretion detectable in 
the urine. Recognising the characteristic clinical manifestations may enable accurate 
diagnosis and inform therapy [22].  
Urine toxicology can be used to confirm cocaine exposure. Drug metabolites 
(most commonly benzoylecgonine) are detectable within 2 hours of use up to 5 days. 
Only 4 patients in our series had positive urine toxicology, the remaining subjects 
had either reported completed cessation of cocaine use or were outside the time 
frame for testing. Urine toxicology screening is preferable to saliva and blood 
toxicology testing due to cost effectiveness and ready availability. We acknowledge 
that patient reported drug cessation may be unreliable given the reluctance to admit 
using illegal substances. It is therefore challenging to accurately determine the 
period between patient reported drug use and onset of vasculitis symptoms.  
Idiopathic AAV requires treatment with potent immunosuppressive agents with 
potential toxicity and associated mortality. In cocaine associated vasculitis, drug 
cessation may result in clinical resolution, negating the requirement for escalation of 
immunosuppression above corticosteroids [6]. Most patients in our series were 
successfully managed with either corticosteroid alone or in combination with steroid 
sparing agents. Standard management guidelines for AAV may not be directly 
applicable to this group of patients. Treatment paradigms should reflect disease 
severity and degree of organ involvement.  
Chronic cocaine use may be associated manifestations that closely parallel 
ANCA associated vasculitis. A comprehensive drug history is a necessity due to 
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possible reluctance to admitting recreational drug use. Urine drug screens should be 
openly discussed with patients. This group of patients may be challenging to treat 
due to variable adherence to therapy and long term follow-up. Referral to drug 
rehabilitation services to assist with managing the physical and psychosocial aspects 
of drug addiction is advised.  
Key Messages 
 Differentiating cocaine induced pseudovasculitis from idiopathic AAV is 
clinically challenging; a thorough drug history and high index of suspicion are 
key 
 Advanced erosive nasal septal defects and atypical ANCA patterns are 
suggestive of cocaine induced pseudovasculitis 
 Complete drug cessation may help negate the need for potent 
immunosuppressive therapy 
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System specific clinical manifestations  
Patie
nt 
Se
x 
M/
F 
Age 
(yea
rs) 
ESR 
(mm
/h) 
CR
P 
(mg/
L) 
Serolo
gy 
(U/ml) 
Creati
nine 
(μmol/L
) 
Duration 
of 
cocaine 
use 
prior to 
first 
presenta
tion 
(years) 
Inflamm
atory 
arthritis 
Skin 
(vascu
litic 
purpur
ic 
rash) 
Periphe
ral 
neurop
athy 
Pulmona
ry 
lesions 
ENT 
lesions 
Tissue 
histology 
1 F 25 18 10 
C-
ANCA 
+ PR3 
57.5 
Repea
t 
ANCA 
- 
64 6 + + - 
None (X-
ray) 
Mucosal 
thickenin
g 
maxillary 
antra. 
Nasal 
septum 
deviation 
with 
large def
ect within 
it. 
Sinus biopsy: 
granulation 
tissue, no 
evidence of 
vasculitis. 
2 F 39 37 127 
P-
ANCA 
+ 
MPO 
22 
Repea
t 
ANCA 
- 
74 12 + - - 
None 
(CT) 
Mucosal 
thickenin
g 
maxillary 
antrum 
and 
ethmoid 
sinuses, 
nasal 
septum 
deviation 
and 
destructio
n of 
posterior 
aspect. 
Destructi
on of the 
nasal 
columella 
and 
upper lip. 
Sinus biopsy: 
fibrosis, acute 
and chronic 
inflammation. 
Necrosis at the 
surface with 
deeper, 
microscopic 
foci of stromal 
necrosis. Foci 
of acute 
venular 
inflammation, 
no fibrinoid 
necrosis. 
Polymorphic 
inflammatory 
cell infiltrate. 
No granuloma 
seen. 
3 M 37 25 47 
C-
ANCA 
+ PR3/ 
MPO – 
Repea
t 
ANCA 
- 
92 
Unconfir
med 
- - + 
None (X-
ray) 
Mucosal 
thickenin
g, 
abnormal 
soft 
tissue 
surroundi
ng middle 
and lower 
turbinate
s with 
erosion 
and nasal 
septal 
deviation. 
Sinus biopsy: 
ulcerated 
granulation 
tissue with 
dense 
inflammatory 
infiltrate with 
neutrophils, 
lymphocytes.  
Renal biopsy: 
moderate 
haematuria. 
Marked fibro-
intimal 
thickening of 
medium caliber 
arteries, no 
evidence of 
acute 
thrombotic 
microangiopath
y. Several foci 
of hyaline 
arteriosclerosis. 
Small focus of 
interstitial 
fibrosis. No 
glomerulonephr
itis. 
4 F 39 30 33 
P-
ANCA 
+ PR3/ 
MPO – 
Repea
t P-
ANCA 
+ 
60 10 + - + 
Solitary 
nodule 
and 
calcified 
granulom
a (CT) 
Maxillary 
antrum 
mucosal 
thickenin
g. 
Thickenin
g of 
osteome
atal 
- 
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PR3/M
PO - 
complex. 
5 M 43 11 10 
P-
ANCA 
+ 
PR3/M
PO – 
Repea
t 
ANCA  
- 
99 
Unconfir
med 
+ - + 
Calcificati
on (CT) 
Mucosal 
thickenin
g of 
ethmoid 
sinuses. 
Polyploid 
thickenin
g of right 
maxillary 
sinus. 
Thickene
d mucosa 
of middle 
and 
inferior 
turbinate
s. 
Sinus biopsy: 
active chronic 
inflammation 
with a focus of 
necrotizing 
vasculitis, 
fibrinous 
necrosis and 
acute 
inflammation of 
a venule. No 
granuloma.  
6 M 38 20 5 
C-
ANCA 
+ PR3 
381 
Repea
t C-
ANCA 
+ PR3 
8.3 
59 15 - + - 
Left hilar 
nodes  
and lower 
lobe 
mass 
(CT) 
Air fluid 
level with 
associate
d 
mucosal 
thickenin
g. Nasal 
septal 
deviation. 
Sinus biopsy: 
ulceration with 
fibrin deposition 
and acute on 
chronic 
inflammation 
with plasma 
cells, 
neutrophils and 
lymphocytes. 
No granuloma 
or vasculitis 
seen. 
7 M 39 10 1 
P-
ANCA 
+ 
PR3/M
PO – 
Repea
t C-
ANCA 
+ 
PR3/M
PO - 
99 
Unconfir
med 
+ - - 
Multi-
lobar 
consolida
tion, 
opacificat
ion, 
nodularity 
(CT) 
 
Air fluid 
level in 
right 
maxillary 
antrum. 
Mucosal 
thickenin
g of 
ethmoid 
air cells. 
Nasal 
septal 
deviation. 
- 
8 M 41 5 25 
C-
ANCA 
+ PR3/ 
MPO – 
Repea
t 
ANCA 
- 
90 10 + - + 
None  (X-
ray) 
Mucosal 
thickenin
g within 
maxillary 
antra. 
Mild 
deviation 
cartilagin
ous nasal 
septum 
with 
extensive 
septum 
defect. 
Minimal 
mucosal 
thickenin
g within 
sphenoid 
sinus and 
ethmoid 
air cells. 
- 
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9 M 53 5 5 
C-
ANCA 
+ 
PR3/M
PO – 
Repea
t 
ANCA 
- 
91 10 + + - 
None (X-
ray) 
- 
Renal biopsy: 
mesangial 
proliferative 
glomerulonephr
itis with 
crescents.  IgA 
and fibrinogen 
deposition in 
mesangial 
matrix. 
Complement 
Deposition. 
Appearances 
suggestive of 
Henoch 
Schonlein 
Purpura.  
Skin biopsy: 
florid 
leucocytoclastic 
vasculitis. Mild 
superficial 
perivascular 
predominantly 
neutrophilic 
inflammatory 
cell infiltrate 
with 
leucocytoclastic
, extravasated 
erythrocytes. 
10 * M 45 18 10 
P-
ANCA 
+ PR3 
69 
Repea
t P-
ANCA 
+ 
PR3/M
PO - 
111 10 + - - 
Pleural 
thickenin
g (CT)  
 
Concentri
c 
mucosal 
hypertrop
hy of 
maxillary 
antra with 
perforatio
n in lower 
bony 
septum. 
Sinus biopsy: 
Marked 
inflammatory 
change, 
densely 
inflamed 
granulation 
tissue with 
lymphocytes, 
neutrophils and 
plasma cells. 
11 * M 40 39 4 
P-
ANCA 
+ PR3 
+ 4.2 
Repea
t P-
ANCA 
+ 
PR3/M
PO - 
73 
Unconfir
med 
+ - - 
Unremar
kable 
appearan
ces (CT) 
Mucosal 
thickenin
g within 
bilateral 
middle 
and 
inferior 
meati. 
Erosion 
of floor of 
nasal 
cavity, 
hard 
palate 
and nasal 
septum. 
Nasal biopsy: 
inflammatory 
features with 
ulceration, no 
evidence of 
vasculitis, 
granuloma or 
malignancy. 
IgG4 plasma 
cells >80%. 
Sclerosing/eosi
nophilic 
angiocentric 
fibrosis noted.  
12 M 38 40 33 
P-
ANCA 
+ 
PR3/M
PO – 
Repea
t P-
ANCA 
+ 
PR3/M
PO - 
76 
Unconfir
med 
- - - 
Non-
specific 
pulmonar
y nodules 
(CT) 
Irregular 
thickenin
g in nasal 
vestibule 
extending 
in to 
inferior 
meatus. 
Occlusive 
tissue in 
left 
middle 
meatus. 
No 
osseous 
or 
destructiv
e lesion. 
Mild to 
moderate 
polyploid 
mucosal 
thickenin
g of the 
maxillary 
antra and 
anterior 
ethmoid 
Nasal biopsy: 
widespread 
mixed 
inflammatory 
infiltrate of 
neutrophils, 
lymphocytes, 
plasma cells 
and 
macrophages. 
No significant 
eosinophil 
infiltrate. 
Vascular 
necrosis and 
inflammation 
nasal 
ulceration.  
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
 
air cells. 
13 * M 37 2 3 
P-
ANCA 
+ PR3 
+ 22.0, 
MPO – 
Repea
t P-
ANCA 
+ PR3 
+ 16, 
MPO -  
99 6 + - + 
None (X-
Ray) 
Patchy 
mucosal 
thickenin
g within 
maxillary 
and 
ethmoid 
sinuses 
bilaterally
, Nasal 
septal 
thickenin
g of left 
middle/inf
erior 
turbinate
s. 
Perforatio
n 
anteriorly 
and 
crowding 
of left 
nasal 
cavity  
Nasal biopsy: 
fibrin slough 
with dense 
neutrophil 
infiltrate. Acute 
inflammation. 
14 * F 32 32 15 
P-
ANCA 
+ PR3 
+ 18 
MPO –  
Repea
t P-
ANCA 
+ PR3 
+ 15, 
MPO - 
 
53 7 - + - 
None (X-
Ray) 
Sinonasa
l mucosal 
thickenin
g, 
obstructio
n of left 
ostioment
al 
complex. 
Bony 
erosion 
of the 
sphenoid 
sinus 
floor with 
bony 
sclerosis.  
- 
Table 1:  Demographics, serology and organ involvement of eleven patients with ANCA-associated vasculitis induced by cocaine. ESR – 
Erythrocyte Sedimentation Rate, CRP – C-Reactive Protein, ENT – Ear, Nose and Throat, CT – Computerised Tomography, C-ANCA - cytoplasmic anti-
neutrophil cytoplasmic antibody, P-ANCA - perinuclear anti-neutrophil cytoplasmic antibody, MPO – myeloperoxidase, PR3 - proteinase 3,* positive urine 
toxicology confirming recent cocaine exposure. 
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